Healthcare ❯ Clinical Research

Clinical Trials

Patient Studies PCOS Studies Regulatory Compliance Stroke Prevention Effectiveness Studies Nutritional Supplements Psychedelic-Assisted Psychotherapy Evidence-Based Medicine Dietary Interventions Women in Research

MAR001 Cuts Triglycerides Dramatically in Phase 2b Trial

Sharp fasting‑triglyceride reductions from ANGPTL4 inhibition could steer development toward treating severe hypertriglyceridemia.

Lilly’s Foundayo Pill Significantly Improves Sleep Apnea in Late‑Stage Trials

Small Study Suggests Pill Could Put Hormone‑Driven High Blood Pressure Into Long‑Term Remission

Two High‑Profile Heart Trials Fail to Cut Events Despite Big Biomarker Drops

FDA Accepts uniQure’s Huntington’s Gene Therapy for Priority Review, Sets May 1, 2027 Decision Date

Moderna and Merck Say Personalized mRNA Vaccine Cuts Melanoma Recurrence by 42%

Nature Medicine Paper Shows Vβ‑Directed Bispecific Expands Targeted T Cells and Triggers Tumor Responses

Targeted Ultrasound Lowers Delusions in Small Schizophrenia Trial

Study Finds Glioblastoma Drug Acts on DHODH Not KDM4

Pomegranate‑Derived Molecule Shows Promise for Hard‑To‑Treat Heart Failure

Boston Scientific Launches $700M–$800M Restructuring and Lowers 2026 Profit Outlook

NovoCure Posts Record Q2 Revenue and Raises 2026 Outlook

Glucotrack and Lōkahi Complete Deal, Creating Lōkahi‑Controlled Public Biopharma Platform

Fennec Q1 Sales Climb 73% to $15.1 Million on PEDMARK Momentum

New Data Tie GLP-1 Drugs’ Broad Benefits to Inflammation

Boston Scientific Meets Q1 Targets and Cuts 2026 Outlook

FDA Clears First Generic Flovent HFA Inhaler as Glenmark Prepares U.S. Launch

Major Review Finds Collagen Modestly Improves Skin and Eases Osteoarthritis—Not Wrinkles

Geron Guides 2026 Rytelo Sales to $220–$240 Million After $184 Million Debut Year

AVITA Medical Sets Feb. 18 Investor Webinar to Review Q4 and 2025 Results